Abstract
Many single-gene mutations that cause epilepsy have been identified1,2 but these cause only a small percentage of idiopathic epilepsies. In most cases, the inherited causes of epilepsy are believed to be additive or multiplicative effects of an unknown number of genes, sometimes interacting with environmental factors.3 Identifying genes that underlie complex diseases is challenging4 and, although both common and rare variants underlying generalized epilepsies have recently been discovered, these account for only a tiny fraction of the attributable genetic risk.5,6 Furthermore, though screening technology is improving and a number of projects are under way to collect data from large populations, there still is a problem of how to perform functional analyses of candidate susceptibility genes. Even in the case of monogenic mutations, functional analysis lags significantly behind mutation discovery. The initial functional analysis of mutations is usually done using patch clamp electrophysiology in heterologous expression systems, with reported functional changes being large and obvious7,8; this, however, misses other, potentially important cell biological effects such as trafficking deficits9-11 and subtle changes in function that would escape detection. More informative techniques such as in vitro or in vivo viral transfections or knockin animal models are costly, time consuming, and cannot meet the demands of genetic screening studies. In the case of susceptibility genes, the interpretation of data is likely to be extremely difficult because, by definition, several susceptibility variants (as well as potential environmental influences) are required to cause a disease; the effects of any 1 variant are likely to be small.12 Furthermore, it is possible that phenotypic expression as an epilepsy is not simply an additive effect of several susceptibility polymorphisms or rare variants, but requires an epistatic interaction between them.

This publication has 21 references indexed in Scilit: